X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
index medicus (38) 38
male (33) 33
female (31) 31
infectious diseases (29) 29
adult (27) 27
immunology (25) 25
hiv (24) 24
genotype (19) 19
hiv infections - genetics (17) 17
interleukins - genetics (17) 17
middle aged (17) 17
association (15) 15
hepatitis c (15) 15
il28b (15) 15
polymorphism, single nucleotide (15) 15
virology (15) 15
hepatitis c virus (14) 14
microbiology (13) 13
aids/hiv (12) 12
hepacivirus - genetics (12) 12
hepatitis (12) 12
hiv infections - drug therapy (12) 12
polymorphism (12) 12
genetic aspects (11) 11
hiv infections - complications (11) 11
viral load (11) 11
prospective studies (10) 10
ribavirin (10) 10
treatment outcome (10) 10
hepatitis c - genetics (9) 9
hiv infection (9) 9
hiv-1 (9) 9
human immunodeficiency virus--hiv (9) 9
infections (9) 9
therapy (9) 9
analysis (8) 8
antiviral agents - therapeutic use (8) 8
disease progression (8) 8
genotypes (8) 8
haplotypes (8) 8
hepatitis c - drug therapy (8) 8
hiv infections - virology (8) 8
infection (8) 8
ribavirin - therapeutic use (8) 8
genetic predisposition to disease (7) 7
hepacivirus - isolation & purification (7) 7
hepatitis c - complications (7) 7
hepatitis c - virology (7) 7
hepatitis c, chronic - drug therapy (7) 7
hepatitis c, chronic - virology (7) 7
hiv infections - immunology (7) 7
interferon (7) 7
medicine (7) 7
multidisciplinary sciences (7) 7
pegylated interferon (7) 7
rna (7) 7
science (7) 7
animals (6) 6
cohort studies (6) 6
gene (6) 6
genetic variation (6) 6
health aspects (6) 6
hepacivirus - classification (6) 6
human immunodeficiency virus (6) 6
interferon-alpha - therapeutic use (6) 6
polyethylene glycols - therapeutic use (6) 6
polymerase chain reaction (6) 6
research article (6) 6
ribavirin - administration & dosage (6) 6
rna, viral - blood (6) 6
spain (6) 6
viral kinetics (6) 6
abridged index medicus (5) 5
aids (5) 5
alleles (5) 5
antiviral agents - administration & dosage (5) 5
biological response modifiers (5) 5
drug therapy (5) 5
expression (5) 5
gastroenterology and hepatology (5) 5
gene expression (5) 5
genetic-variation (5) 5
genotype & phenotype (5) 5
hepatitis c, chronic - genetics (5) 5
interferon alpha-2 (5) 5
interferon-alpha - administration & dosage (5) 5
liver (5) 5
mice (5) 5
rapid virological response (5) 5
recombinant proteins (5) 5
alfacalcidol (4) 4
biology (4) 4
calcifediol (4) 4
care and treatment (4) 4
cell line (4) 4
chemokine (4) 4
chemokine cxcl12 (4) 4
chemokine receptor cxcr4 (4) 4
coinfection (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 10/2010, Volume 51, Issue 7, pp. 788 - 795
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61992
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 10, pp. 1209 - 1216
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 11, pp. 1629 - 1636
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e95515
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e48959
Background: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-alpha 2a/RBV therapies on HCV viral decline in HIV/HCV... 
VIRUS-INFECTION | PEGINTERFERON ALPHA-2A | KINETICS | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PEGYLATED INTERFERON | HIV COINFECTION | ALPHA-2A PLUS RIBAVIRIN | INFECTED PATIENTS | COMBINATION | PREDICTION | Prospective Studies | Hepatitis C - drug therapy | Coinfection - drug therapy | Humans | Hepacivirus - genetics | Male | Dose-Response Relationship, Drug | Hepatitis C - blood | Ribavirin - administration & dosage | Adult | Female | HIV Infections - blood | Antiviral Agents - therapeutic use | HIV Infections - genetics | HIV Infections - virology | Genotype | Hepatitis C - genetics | Treatment Outcome | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | HIV - growth & development | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Coinfection - genetics | Hepatitis C - virology | HIV - genetics | HIV Infections - drug therapy | Hepacivirus - growth & development | Viral Load - drug effects | Infection | Care and treatment | Analysis | HIV patients | Genetic aspects | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Standards | Ribavirin | Biomedical research | Liver | Regression analysis | Dosage | Patients | Impact analysis | Hepatitis | α-Interferon | Regression models | Infectious diseases | Polyethylene glycol | Biopsy | Hepatology | Human immunodeficiency virus--HIV | Drug dosages | HIV | Human immunodeficiency virus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 9, p. e106442
Journal Article
Journal Article